The Latest Breaking News from Vaccine

Trump Adds to Wealth With Moderna Stock Gains: Here’s How Much President Made

Moderna Inc. (NASDAQ:MRNA) stock soared Wednesday after the company and Merck reported positive Phase 3 results for a personalized mRNA cancer vaccine, marking a major milestone for the emerging technology. Shares jumped more than 100%, reaching levels not seen since May 2024.

Benzinga · Aug 19

Who Is Dr. Heidi Overton? Trump's FDA Nominee Once Stood By Him Over False Autism-Vaccine Claim

President Trump nominates Dr. Heidi Overton to lead the FDA, sparking controversy over her stance on vaccination protocols and facing a divided Senate for confirmation amidst ongoing public health challenges.

International Business Times UK · Aug 19

Breakthrough Personalized mRNA Vaccines Are Highly Effective Against Melanoma Skin Cancers

The vaccine could be available as soon as 2027.

Reason · Aug 19

Trump nominates abortion opponent Heidi Overton to be head of FDA

Overton has said that Congress should strictly regulate abortion drug mifepristone ‘to protect women and children’

The Guardian - US · Aug 19

Moderna Shares Double Overnight Because a Made-to-Order mRNA Vaccine Actually Beats Skin Cancer

Moderna's personalised mRNA cancer vaccine, intismeran, significantly reduces melanoma recurrence in a Phase 3 trial, doubling the company's stock value and marking a milestone in cancer treatment.

International Business Times UK · Aug 19

Possible Skin Cancer Vaccine Shows Promise In Late Stage Trial. Moderna Stock Skyrockets.

The late-stage clinical trial was described as a "landmark moment."

International Business Times · Aug 19

Moderna shares soar 159% in a day after cancer vaccine succeeds in late-stage trial

Moderna shares surged after its personalized mRNA cancer vaccine trial showed positive results. The treatment, combined with Keytruda, reduced melanoma recurrence and spread significantly. This marks the first successful late-stage trial for an mRNA cancer vaccine. The findings offer hope for future growth beyond COVID-19 vaccines. Discussions with regulators are…

The Economic Times · Aug 19

Most American Adults Show No Measurable Immunity to Hepatitis A or B Despite Decades of Vaccines

A JAMA Internal Medicine analysis found 39.5% of US adults had serologic immunity to hepatitis A and just 27.1% had it for hepatitis B.

Medical Daily · Aug 19

The CDC has a new director – now comes the hard part

The new director of the Centers for Disease Control and Prevention, Erica Schwartz, confirmed by the U.S. Senate on Aug. 5, 2026, is only the second CDC director to face Senate confirmation. Congress adopted the process for the agency after the COVID-19 pandemic to bring more scrutiny to one of…

The Conversation · Aug 19

Trump Chosen White House Adviser Dr. Heidi Overton to Lead FDA Amid Outbreaks

Trump has chosen White House adviser Dr. Heidi Overton to lead the FDA, an agency down more than 3,000 staff amid open food outbreaks.

Medical Daily · Aug 19